Home/Filings/4/0001415889-25-006154
4//SEC Filing

Mitchell Shawnte 4

Accession 0001415889-25-006154

CIK 0001750284other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:18 PM ET

Size

5.5 KB

Accession

0001415889-25-006154

Insider Transaction Report

Form 4
Period: 2025-02-28
Mitchell Shawnte
CHIEF LEGAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-28+450,000450,000 total
    Exercise: $4.37Exp: 2035-02-27Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001749432

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:18 PM ET
Size
5.5 KB